Who
Saurabh Saha
Director
Company insider
Files Form 4 as: Director, Clarivate; Chief Executive Officer, Centessa Pharmaceuticals.
In numbers
- Trades disclosed
- 76
- Buys
- 4
- Sells
- 25
- Bought
- $632K
- Sold
- $15.3M
- Companies
- 2
- Companies where not an officer
- 1
- First trade
- 16 Nov 2021
- Last trade
- 14 May 2026
- Last filed
- 15 May 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 14 May 2026filed 15 May 2026 | CLVT ClarivatePayments & Processors | SEC FORM 4 Code A | —62,264 at $0.00 | filing |
| 14 May 2026filed 15 May 2026 | CLVT ClarivatePayments & Processors | SEC FORM 4 Code A | —62,264 at $0.00 | filing |
| 13 May 2026filed 15 May 2026 | CLVT ClarivatePayments & Processors | SEC FORM 4 Code F | $20K8,178 at $2.44 | filing |
| 13 May 2026filed 15 May 2026 | CLVT ClarivatePayments & Processors | SEC FORM 4 Code F | $20K8,178 at $2.44 | filing |
| 21 Jul 2025filed 21 Jul 2025 | Centessa Pharmaceuticalsoption or derivative | SEC FORM 4 Code M | —55,000 at $0.00 | filing |
| 21 Jul 2025filed 21 Jul 2025 | Centessa Pharmaceuticals | SEC FORM 4 Code M | $212K55,000 at $3.85 | filing |
| 21 Jul 2025filed 21 Jul 2025 | Centessa Pharmaceuticals | SEC FORM 4 Sold | $876K55,000 at $15.92 | filing |
| 20 Jun 2025filed 20 Jun 2025 | Centessa Pharmaceuticalsoption or derivative | SEC FORM 4 Code M | —55,000 at $0.00 | filing |
| 20 Jun 2025filed 20 Jun 2025 | Centessa Pharmaceuticals | SEC FORM 4 Code M | $212K55,000 at $3.85 | filing |
| 20 Jun 2025filed 20 Jun 2025 | Centessa Pharmaceuticals | SEC FORM 4 Sold | $695K55,000 at $12.63 | filing |
| 20 May 2025filed 20 May 2025 | Centessa Pharmaceuticalsoption or derivative | SEC FORM 4 Code M | —55,000 at $0.00 | filing |
| 20 May 2025filed 20 May 2025 | Centessa Pharmaceuticals | SEC FORM 4 Code M | $212K55,000 at $3.85 | filing |
| 20 May 2025filed 20 May 2025 | Centessa Pharmaceuticals | SEC FORM 4 Sold | $699K55,000 at $12.71 | filing |
| 7 May 2025filed 8 May 2025 | CLVT ClarivatePayments & Processors | SEC FORM 4 Code A | —39,473 at $0.00 | filing |
| 6 May 2025filed 8 May 2025 | CLVT ClarivatePayments & Processors | SEC FORM 4 Code F | $21K4,974 at $4.17 | filing |
| 22 Apr 2025filed 22 Apr 2025 | Centessa Pharmaceuticals | SEC FORM 4 Sold | $501K40,344 at $12.43 | filing |
| 21 Apr 2025filed 22 Apr 2025 | Centessa Pharmaceuticals | SEC FORM 4 Sold | $180K14,656 at $12.29 | filing |
| 20 Mar 2025filed 21 Mar 2025 | Centessa Pharmaceuticals | SEC FORM 4 Sold | $918K55,000 at $16.69 | filing |
| 3 Mar 2025filed 5 Mar 2025 | CLVT ClarivatePayments & Processors | SEC FORM 4 Bought | $254K58,275 at $4.36 | filing |
| 20 Feb 2025filed 20 Feb 2025 | Centessa Pharmaceuticals | SEC FORM 4 Sold | $863K54,225 at $15.92 | filing |
News
Clarivate Demonstrates Global Demand For AI-native Web Of Science Research IntelligenceCLVT · prnewswire.com · 22 Oct 2026
0 headlines in the last 90 days name Saurabh Saha; 1 article from the last 14 days about the 1 company they traded most, at most three about any one of them.